The ReactorTM

Placement of a chest tube into the thoracic cavity has been around for more than 100 years with virtually no change in technique! Imagine driving a Model T car today down the highway – would it be as safe, fast, effective and reliable as a modern car at 65 MPH? The ReactorTM offers medical professionals a revolutionary way to insert chest tubes into the thoracic cavity. In other words, it is minimally invasive compared to the open technique! Putting this in perspective, how many appendectomies are still done with an open incision? The ReactorTM has been sold since 2015 and has multiple issued and pending patents.

Sharp Medical Products, LLC is also planning even more enhancements in the form of a “generation 2” device with an anticipated availability date of 2019. For more information Click Here

N-G Tube

The first use of a tube in the stomach appears to have been with a silver tube in the 17th century by Fabricius ab Aquapendente, a professor of surgery. In 1790, John Hunter fed a patient via a hollow leather tube for 5 weeks. Despite more than 200 years of usage, N-G tubes still suffer from 2 fundamental problems; painful insertion and difficulty with ongoing aspiration of stomach contents. Sharp Medical Products, LLC (SMP) has addressed these two core problems and has begun work to improve them.

O2MAX®

Simple oxygen face masks were patented in the 1950s and there has been relatively little improvement in oxygen delivery; the typical mask delivers ~40-50% oxygen even when run at 15 L of oxygen per minute. Sharp Medical Products, LLC (SMP) has redesigned the face mask from virtually the ground up to create our mask called “O2MAX®”. 3 Research studies have bene performed to date on “O2MAX®”. O2MAX® has 9 critical enhancements resulting in oxygen delivery of up to 64% more than market leading masks! This game changing technology has been developed in such a way that “O2MAX®” will not cost more than other masks to manufacture.

SMP has applied for 2 patents, build commercial grade articles and is presently in discussions with international companies for the purchase or license of this technology.

“O2MAX®” potentially could replace the estimated 1.2 billion face masks presently being used annually throughout the world.

SMP Enters into an Exclusive Distribution

Sharp Medical Products, LLC Enters into an Exclusive Distribution Agreement with Panakeia, LLC, to Market and Distribute the ReactorTM Chest Tube Insertion Device to the U.S. Military Health System.

Geneva, IL – Sharp Medical Products, LLC, a privately held company and maker of the ReactorTM, announced that it has entered into a distribution agreement with Panakeia, LLC, a leading firm specializing in marketing and distributing innovative medical products and services to the United States Military Health System, to market and distribute its revolutionary chest tube
insertion device worldwide. Approved by the FDA for commercial distribution in 2015, the ReactorTM offers medical professionals a revolutionary way to insert chest tubes into the thoracic cavity to drain blood, air or infections. Placement of a chest tube into the thoracic cavity has been around for more than 100 years with virtually no change in technique – until now!

Some of the design features of the ReactorTM to markedly improve the insertion of chest tubes include:

  • Rotating and retracting blade (carves not punctures through tissue)
  • Oval shaft (fits between ribs better than round)
  • Chest wall tunnel – (creates a constant diameter narrow tunnel of ~ 1 cm)

Potential advantages of the ReactorTM include smaller incision and faster procedure times. Other advantages may become clear with time.

“We are excited to have Panakeia represent the ReactorTM, to the military”, said Dave Sash, National Sales Director for Sharp Medical Products.. “Their attention to detail, quality systems, well trained staff, and in-depth knowledge of the Military Health System, make this unique partnership extremely valuable.” “We believe that with Panakeia representing the ReactorTM we will have the best exposure of our chest tube insertion device to the U.S. military and provide a revolutionary device for our soldiers on the battlefield”
“We are pleased to be the exclusive distributor for Sharp Medical and bring their innovative products to the Federal Market”, said Pam Jackson, COO of Panakeia., “Sharp Medical’s ingenuity of their REACTORTM will, for the first time in history, change the way chest tube insertion procedures are accomplished.

For more information about Panakeia, LLC visit www.panakeiausa.com or call 202-656-8848.
Sharp Medical Products, LLC. was founded by a U.S. surgeon. Both U.S. and international patents have been issued. For more information visit www.sharpmedicalproducts.com or call 630-232-8002.

SMP Receives FDA Approval for the ReactorTM

Sharp Medical Products, LLC Receives FDA Approval for the ReactorTM Chest Tube Insertion Device

Geneva, IL – Sharp Medical Products, LLC, a privately held company and maker of the ReactorTM, announced today that the U.S. Food and Drug Administration (FDA) has cleared the Reactor Chest Tube Insertion Device for commercial distribution. The ReactorTM offers medical professionals a revolutionary way to insert chest tubes into the thoracic cavity to drain blood, air or an infection. Placement of a chest tube into the thoracic cavity has been around for more than 100 years with virtually no change in technique – until now!

Some of the design features of the ReactorTM to markedly improve the insertion of chest tubes includes:

  • Rotating and retracting blade (carves not punctures through tissue)
  • Oval shaft (fits between ribs better than round)
  • Chest wall tunnel – (creates a constant diameter narrow tunnel of ~ 1 cm)

Potential advantages of the ReactorTM include smaller incision and faster procedure times. Other advantages may become clear with time.

“We are ecstatic to have received our FDA approval to begin to market and sell the ReactorTM,” said Dave Sash, National Sales Director for Sharp Medical Products. “The ReactorTM is truly one of those unique medical devices that can help revolutionize medicine – it is not an incremental change but a quantum leap improvement for the insertion of chest tubes into the thoracic cavity – the present method has been around for more than 100 years with virtually no improvement.”

Sharp Medical Products, LLC. was founded by a U.S. surgeon. Both U.S. and international patents have been issued. For more information visit www.sharpmedicalproducts.com or call 630-232-8002.